Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Motif Bio

19 Mar 2020 17:30

RNS Number : 8768G
FTSE Russell
19 March 2020
 

 

Motif Bio (UK): Constituent DeletionChanges in FTSE UK Index Series

19 March 2020

Following the reclassification to AIM Rule 15 (Cash Shell) for Motif Bio (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE AIM All-Share Index

24 March 2020

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 4563 6346

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2020 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSUKSNRRSUOAAR
Date   Source Headline
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSCorporate Update
12th Mar 20204:42 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 202012:02 pmRNSPrice Monitoring Extension
7th Feb 20204:35 pmRNSPrice Monitoring Extension
28th Jan 20204:40 pmRNSSecond Price Monitoring Extn
28th Jan 20204:35 pmRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSCorporate Update
22nd Jan 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20204:35 pmRNSPrice Monitoring Extension
17th Jan 202012:12 pmRNSHolding(s) in Company
16th Jan 20204:41 pmRNSSecond Price Monitoring Extn
16th Jan 20204:35 pmRNSPrice Monitoring Extension
16th Jan 202012:07 pmRNSSecond Price Monitoring Extn
16th Jan 202012:02 pmRNSPrice Monitoring Extension
14th Jan 202012:35 pmRNSHolding(s) in Company
10th Jan 20209:55 amRNSHolding(s) in Company
6th Jan 20204:40 pmRNSSecond Price Monitoring Extn
6th Jan 20204:35 pmRNSPrice Monitoring Extension
3rd Jan 202010:42 amRNSHolding(s) in Company
23rd Dec 20199:45 amRNSHolding(s) in Company
19th Dec 20194:29 pmRNSHolding(s) in Company
19th Dec 20194:25 pmRNSHolding(s) in Company
10th Dec 20197:00 amRNSVoluntary delisting from the NASDAQ Capital Market
6th Dec 201911:14 amRNSHolding(s) in Company
29th Nov 201912:20 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights
27th Nov 20197:00 amRNSADS Program and Warrant Agent Agreement
26th Nov 20197:00 amRNSVoluntary Delisting from the Nasdaq Capital Market
20th Nov 20195:51 pmRNSHolding(s) in Company
18th Nov 201912:12 pmRNSDirectorate Changes
14th Nov 20196:13 pmRNSResult of General Meeting
11th Nov 20197:00 amRNSSettlement Agreement
28th Oct 20194:14 pmRNSHolding(s) in Company
25th Oct 20193:51 pmRNSHolding(s) in Company
25th Oct 201912:07 pmRNSSecond Price Monitoring Extn
25th Oct 201912:02 pmRNSPrice Monitoring Extension
25th Oct 20197:00 amRNSPosting of Circular and Notice of General Meeting
24th Oct 20197:00 amRNSU.S. Army-funded project to Evaluate Iclaprim
21st Oct 20193:00 pmRNSTiming of General Meeting and Circular
21st Oct 201912:07 pmRNSSecond Price Monitoring Extn
21st Oct 201912:02 pmRNSPrice Monitoring Extension
10th Oct 20197:00 amRNSMotif Bio confirms receipt of FDA meeting minutes
3rd Oct 201912:07 pmRNSSecond Price Monitoring Extn
3rd Oct 201912:02 pmRNSPrice Monitoring Extension
3rd Oct 20197:00 amRNSChange of Adviser
2nd Oct 20197:00 amRNSConditional Placing
30th Sep 20194:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.